AASLD The Liver Meeting

Claudia is Board Certified in nutrition and metabolism and offers 20+ years of pharmaceutical and CRO experience in Phase II-IV clinical research. Claudia joined Fortrea (previously Labcorp Drug Development) in 2014 and started building the Liver Therapeutic Area. She is currently heading the Liver medical team, responsible for the medical oversight and for providing strategic medical consultation. She is also chairing the Innovative Study Design working group. Claudia has comprehensive experience in leading drug development programs with her main focus in metabolics and liver indications. 

Claudia is a member of the Liver and PSC Forum, AASLD steatohepatitis working group and EASL NAFLD group. She has authored multiple manuscripts, including five recent review papers about clinical development in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and adaptive design studies.

Sonia Preston is a Senior Director in Strategic Delivery & Growth for Infectious Diseases and Critical Care and is based near Salt Lake City, Utah. Sonia has more than 25 years of clinical research experience including working as a study coordinator for the VA and in a university setting, in major pharma and for the CRO industry in senior positions of leadership in both project management and strategy. Her therapeutic focus within the last five years has been in infectious and immunological diseases, multiple therapeutic areas of rare diseases, renal, cardiovascular, and pulmonary indications. She has been in drug development in Phases I-IV with expertise in pediatric studies and hybrid study designs. 

Sonia is a certified Green Belt in Six Sigma and has been certified as a Project Management Professional (PMP) since 2003 and remains an active member of the Project Management Institute. She earned her master's degree in operational management from the University of Washington. She joined our company in 2006.